Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Videos
Diagnostics
In Vitro Diagnostics
Return to: MDBR Home | Diagnostics | In Vitro Diagnostics | News
Search Refinements

In Vitro Diagnostics News

View news from other Medical Devices sectors:
541-555 of 2993 results
Harvard’s Wyss Institute launches updated sepsis therapeutic device
By MDBR Staff Writer
Harvard University’s Wyss Institute for Biologically Inspired Engineering has launched an updated version of its blood-cleansing device that treats sepsis by mimicking human spleen.
Diagnostics > In Vitro Diagnostics > News
Guardant Health and Flatiron Health to develop innovative data platform to advance precision medicine for cancer and enhance patient care
By MDBR Staff Writer
Guardant Health and Flatiron Health announced a strategic collaboration to build a proprietary, cloud-based information platform integrating liquid biopsy-based genomic testing with clinical treatment and outcomes data to support the accelerated development of targeted therapies for cancer.
Diagnostics > In Vitro Diagnostics > News
BioMark Diagnostics announces progress in assay validation for clinical sample analysis
By MDBR Staff Writer
BioMark Diagnostics, a leader in next-generation diagnostics using metabolites, is pleased to announce that the assay validation to analyze the clinical samples from the Company's first 200-patient trial is anticipated to be completed within four weeks.
Diagnostics > In Vitro Diagnostics > News
OPKO Lab signs contracts with leading preferred provider networks for laboratory testing services
OPKO Health announced that it has entered into agreements with Stratose, Three Rivers Provider Network and Fortified Provider Network for testing services from OPKO Lab, including the 4Kscore Test, the only blood test that accurately identifies an individual patient’s risk for high-grade, aggressive cancer.
Diagnostics > In Vitro Diagnostics > News
Roche to buy US-based Kapa Biosystems
By MDBR Staff Writer
Switzerland-based Roche has signed an agreement to acquire US-based Kapa Biosystems, for an undisclosed amount.
Diagnostics > In Vitro Diagnostics > News
Ashion Analytics introduces new GEM Cancer Panel
By MDBR Staff Writer
Ashion Analytics has introduced new Genomic Enabled Medicine (GEM) Cancer Panel, which will help doctors to treat patients with cancer.
Diagnostics > In Vitro Diagnostics > News
Ortho Clinical Diagnostics obtains FDA 510(k) approval for Ortho Vision analyzer
By MDBR Staff Writer
Ortho Clinical Diagnostics has received 510(k) approval from the US Food and Drug Administration (FDA) for its automated Ortho Vision analyzer, developed for transfusion medicine laboratories.
Diagnostics > In Vitro Diagnostics > News
True Health Diagnostics launches new personalized patient management tool
By MDBR Staff Writer
True Health Diagnostics has introduced a new personalized patient management tool, which can identify changes in metabolism and risk of chronic disease several years ahead of traditional markers.
Diagnostics > In Vitro Diagnostics > News
Myriad receives favorable medicare final coverage decision for Prolaris test
By MDBR Staff Writer
Myriad Genetics announced that Noridian, the Medicare Administrative Contractor (MAC) for Myriad, has issued a final local coverage determination (LCD) for Prolaris, Myriad's pioneering prognostic test for assessing the aggressiveness of prostate cancer.
Diagnostics > In Vitro Diagnostics > News
ABR launches bovine polyomavirus testing service
By MDBR Staff Writer
ABR (now a VMRD division) announced the availability of a new testing service that can detect the presence of bovine polyomavirus (BPyV) in animal origin products, master virus seeds, and other sample types.
Diagnostics > In Vitro Diagnostics > News
Provista completes enrollment in biomarker assay’s second cohort to detect breast cancer
By MDBR Staff Writer
Molecular diagnostics firm Provista Diagnostics has completed the enrollment of patients in the second cohort of a prospective study of its protein-based biomarker blood test to detect breast cancer.
Diagnostics > In Vitro Diagnostics > News
Roche to buy in vitro diagnostics firm GeneWEAVE for $425m
By MDBR Staff Writer
Switzerland’s Roche has entered into an agreement to acquire US-based in vitro diagnostics firm GeneWEAVE BioSciences for around $425m.
Diagnostics > In Vitro Diagnostics > News
NOWDiagnostics obtains FDA 510(k) approval for ADEXUSDx test
By MDBR Staff Writer
NOWDiagnostics has received 510(k) approval from the US Food and Drug Administration (FDA) for its ADEXUSDx hCG point-of-care test, which allows health care professionals in an early detection of pregnancy in different clinical and critical care settings.
Diagnostics > In Vitro Diagnostics > News
Instrumentation Laboratory launches HemosIL Rivaroxaban Testing Solution in Europe
By MDBR Staff Writer
Instrumentation Laboratory (IL) announced the commercialization of their HemosIL Rivaroxaban Testing Solution in Europe.
Diagnostics > In Vitro Diagnostics > News
UK researchers develop new urine test to identify early stage pancreatic cancer
By MDBR Staff Writer
Researchers from Barts Cancer Institute (BCI) in the UK have developed a new urine test that will help in the detection of early stage pancreatic cancer.
Diagnostics > In Vitro Diagnostics > News
541-555 of 2993 results